Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data-Reference-Cited by-同舟云学术

Effects of adjunctive brexpiprazole on patient life engagement in major depressive disorder: Post hoc analysis of Inventory of Depressive Symptomatology Self-Report data

Published:2023-06 Issue: Volume:162 Page:71-78
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

McIntyre Roger S.,Therrien François^ORCID,Ismail Zahinoor^ORCID,Meehan Stine R.,Miguelez Maia,Larsen Klaus Groes,Chen Dalei,MacKenzie Erin M.,Thase Michael E.

Funder

Otsuka Pharmaceutical Development and Commercialization

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference43 articles.

1. Diagnostic and Statistical Manual of Mental Disorders,2000

2. Meaning in life: resilience beyond reserve;Bartrés-Faz;Alzheimer's Res. Ther.,2018

3. Differences in perceptions of major depressive disorder symptoms and treatment priorities between patients and health care providers across the acute, post-acute, and remission phases of depression;Baune;Front. Psychiatr.,2019

4. The noradrenergic symptom cluster: clinical expression and neuropharmacology;Blier;Neuropsychiatric Dis. Treat.,2011

5. Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ);Chandler;CNS Neurosci. Ther.,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjunctive Brexpiprazole for Patient Life Engagement in Major Depressive Disorder: A Canadian, Phase 4, Open-Label, Interventional Study: Brexpiprazole d'appoint pour l'engagement dans la vie des patients souffrant de trouble dépressif majeur: une étude interventionnelle canadienne ouverte de phase 4;The Canadian Journal of Psychiatry;2024-03-01